MTPConnect is guided by an experienced Board of Directors and supported by a talented executive team.
The Board of Directors
Sue MacLeman – Chair
Sue MacLeman has more than 30 years’ experience as a pharmaceutical, biotechnology and medical technology executive having held senior roles in corporate, medical, commercial and business development. Sue has also served as CEO and Board member of several ASX and NASDAQ listed companies in the pharmaceutical sector and is currently Chair of MTPConnect (MTPII-GC Ltd), Chair of Anatara Lifesciences Ltd (ASX:ANR), Chair of Novita Healthcare Ltd (ASX:NHL), Non-Executive Director of Palla Pharma Ltd (ASX:PAL), Non-Executive Director of Oventus Medical Ltd (ASX:OVN) and Non-Executive Director of veski. Sue is also appointed to several academic and government advisory committees.
Dr Nicholas Cerneaz – Director
Dr Cerneaz has been building companies to commercialise academic research for more than two decades. After gaining a D. Phil (doctorate) in mammography technologies assisting the management of breast cancer from Oxford University in the early 1990s, he has worked extensively guiding the development of a number of medical technology startup companies, covering fields from radiology, oncology, ophthalmology and now pathology. Other industrial experience includes automation and process optimisation in heavy manufacturing and process industries, astronomy instrumentation design and implementation, and advanced computer vision safety systems for the automotive industry. His latest endeavour is MyHealthTest Pty Ltd - a Canberra based medtech startup bringing convenient pathology services to the consumer with do-it-yourself (at home) sample collection and test results delivered online to both the consumer and their doctor. Dr Cerneaz has previously been a director of AIM listed companies, and is today a director of the Australian Centre for Innovation and International Competitiveness (ACIIC) and a scientific advisory board member to Bionic Vision Australia.
Julie Phillips – Director
Julie Phillips has a strong background in the biotech and pharmaceutical industry, having worked as the CEO and Director of start-up Australian biotechnology companies operating in the life sciences sector. Her technical background is in clinical trials, regulatory affairs and pharmacoeconomic assessment/pricing of therapeutics. Ms Phillips is currently Chair of AusBiotech Ltd, the peak biotechnology industry association in Australia, CEO and Director of biotechnology company, BioDiem Ltd and its subsidiary Opal Biosciences, Ltd. She is a member of the Council of the University of Newcastle, and Innovation Australia’s R&D Incentive Committee.
Dr Douglas Robertson – Director
Dr Robertson is the Director of Research Services at The Australian National University and has over 30 periods’ experience in research, economic development, technology transfer, spin-out companies and commercialisation in the UK and Australia. During that time he has negotiated over $3bn of research funding, served on the boards of over 20 technology companies and assisted the establishment of over 20 other early stage technology businesses. Dr Robertson was a founding Director of PraxisUnico (formerly Praxis), a major UK and international technology transfer and training association, from 2003-2013 and Chair in 2012 and 2013. Dr Robertson serves on the boards of four NCRIS facilities.
Phillip Hains – Company Secretary
Mr Hains holds almost 30 years experience in corporate accounting, administration, and general management, and has served on a number of public company boards and related committees. Phillip is driven to achieve, and finds continual inspiration in his colleagues and employees. His depth of experience in the corporate world has also taught him that successful people know how to have fun.He is the founder of The CFO Solution, and is a passionate advocate of The Australian Outward Bound Foundation (OBA). Mr Hains has given back to the community through his sponsorship and pro bono work for OBA, as well as assisting many of his friends, family and staff to attend OBA courses. He is currently a Director and Treasurer/Secretary of OBA. Mr Hains holds an MBA from RMIT University and obtained his Public Practice Certificate from Chartered Accountants Australia and New Zealand in 1998.
Dr Dan Grant - Managing Director & Chief Executive Officer
Dr Dan Grant has spent more than 25 years in senior roles in the pharmaceutical, higher education and medical research sectors. Prior to joining MTPConnect, Dr Grant was the inaugural Pro Vice Chancellor for Industry Engagement at La Trobe University where he had oversight of the university's innovation, commercialisation and industry engagement activities. He was also the Senior Director and Head of Pfizer's External Research and Development Innovation group for ANZ/Singapore and their head of open innovation. Dr Grant was also a member of the United Nations ESCAP SBN Task Force on innovation and competitiveness. He has a PhD in Cardiovascular Physiology and an MBA.
Stuart Dignam – Chief Operating Officer
Stuart Dignam is an accomplished corporate affairs professional. He has 16-years’ experience in media relations, communications and issues management working across political offices and the public and private sectors. Mr Dignam has also worked in broadcast media for more than a decade. He has experience in driving media positioning in Asia, including China, Hong Kong, Malaysia and Singapore. Mr Dignam also has on-the-ground experience in the United States, Canada and Latin America, including Colombia, Brazil, Mexico, Peru and Chile. He has held a number of senior positions, including General Manager, Policy & Corporate Affairs at CPA Australia, Queensland Deputy Trade & Investment Commissioner for the Americas, based in Los Angeles, Executive Director, office of the Director-General of Premier and Cabinet, Queensland and Journalist and broadcaster, ABC News Radio. Mr Dignam has also worked as a government media and policy advisor.
Dr Alfredo Martinez-Coll – General Manager, Stakeholder Engagement
Dr Alfredo Martinez-Coll is a Graduate of the Australian Institute of Company Directors, a Registered Technology Transfer Professional and a member of the AusMedTech (Medical Devices) National Committee of AusBiotech. With a B.S. in Biomedical Engineering from Louisiana Tech University (USA), a PhD and post-doctoral training in biomedical sciences from University of Technology, Sydney, Alfredo brings more than 16 years research experience in the areas of artificial organs, cardiovascular and cerebrovascular physiology, membrane transport, and oxygen transport to tissue. Alfredo has worked as a business development manager in Technology Transfer/commercialisation for the past 13 years at public hospitals and in academia. His main areas of interest are sustainable funding for science, entrepreneurship and innovation, project management in science and business development. Alfredo is passionate about engaging with researchers and Industry specialists in the Life Sciences arena to translate research discoveries into social impact. Prior to joining MTPConnect, Alfredo held the position of Senior Business Development Manager at UNSW Innovations.
Dr Kate Brooks - Director Stakeholder Engagement Western Australia
Dr Kate Brooks is our Director of Stakeholder Engagement for Western Australia. Kate has a Bachelor of Science, Physics, from the University of Wollongong and Doctor of Philosophy, Physics, from UNSW. She joins us from a role as Innovation Manager at Wesfarmers Chemicals, Energy & Fertilisers. She previously worked for the CSIRO, as Deputy Head Operations, Australia Telescope National Facility, where she was responsible for the day-to-day site operations of CSIRO’s five radio astronomy sites across Australia – Parkes and Narrabri sites in NSW plus the newly established Murchison Radio-astronomy Observatory (MRO), Geraldton MRO Support Facility and Boolardy Accommodation Facility, all in WA. She has previously been a research scientist with CSIRO Astronomy and Space Science.
Andrew Bowskill - Director Stakeholder Engagement Queensland
Andrew Bowskill is our Director of Stakeholder Engagement for Queensland, working from the MTPConnect office at the Translational Research Institute (TRI) in Woolloongabba, Brisbane. Andrew joins us from Medicines Australia, where he was Manager of Industry and Regulatory Policy, engaging with a broad cross section of stakeholders including consumer groups, companies, peak bodies and Commonwealth and State officials. As well as his extensive networks, Andrew brings deep understanding of MTP industry and regulatory policy including R&D policy, intellectual property, trade agreements and biosimilars. Andrew has a Bachelor of Pharmacy from the University of Otago and has held a number of pharmacy roles in Queensland including Clinical Pharmacist, Adult Emergency and Medical Admissions and Planning Unit, Mater Pharmacy Services and Team Leader, Mater Private Hospital Pharmacy.
Elizabeth Stares – Director, Major Projects
Ms Stares is an accomplished product designer, specialising in designing medical devices, surgical tools and consumer products for UK and worldwide markets, and was a lead inventor on multiple in-force US patent families.
Ms Stares' medical and consumer devices project management experience has seen her leading and delivering large EU-Government funded projects with numerous partners across multiple countries, and projects values up to $2.7 million. Following a move to Australia in 2010, and a role in a design consultancy and as a product design advisor to various start-up companies, she worked with the MTPConnect Chair and advisor group to determine the need and remit for the Growth Centre, and manage its establishment. Ms Stares is now the Director of Major Projects, working with collaborative consortium on current and future MTPConnect projects; focusing on projects that solve constraints and gaps in the sector or build national capacity, all sharing in a funding pool of $15.6 million.
Danielle Shand - Biomedical Translation Bridge (BTB) Program Operations and Events Manager
Danielle worked in business operations within the pharmaceutical industry and has more than 15 years of background experience in business administrative management. During this time she has continually evolved and developed enhanced leadership skills for working in today’s digital and agile environments. At Pfizer, she played an integral role in shaping, developing and growing the Australia and New Zealand Oncology Business Unit (ANZOBU) platform and its people. Danielle worked collaboratively to ensure strategic planning, budgeting and operation initiatives within marketing were executed, monitored and that the deliverables were in alignment with the priorities and Pfizer’s imperatives. Through active leadership in a matrix environment she drove internal / external communication campaigns, carried out important project management and business analysis work to ensure that goals, objectives and growth projections were achieved.